Geode Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$771K Buy
73,423
+7,976
+12% +$77.8K ﹤0.01% 3439
2025
Q4
$753K Buy
65,447
+2,091
+3% +$32.3K ﹤0.01% 3459
2025
Q3
$1.54M Buy
63,356
+100
+0.2% +$1.67K ﹤0.01% 3270
2025
Q2
$1.04M Sell
63,256
-48,250
-43% -$833K ﹤0.01% 3313
2025
Q1
$2.03M Buy
111,506
+5,432
+5% +$155K ﹤0.01% 3024
2024
Q4
$3.94M Buy
106,074
+756
+0.7% +$28.9K ﹤0.01% 2857
2024
Q3
$3.37M Buy
105,318
+7,349
+8% +$408K ﹤0.01% 2945
2024
Q2
$8.04M Buy
97,969
+13,299
+16% +$1.44M ﹤0.01% 2463
2024
Q1
$12.3M Buy
84,670
+2,248
+3% +$190K ﹤0.01% 2200
2023
Q4
$7.59M Buy
82,422
+7,975
+11% +$811K ﹤0.01% 2481
2023
Q3
$12.3M Buy
74,447
+6,585
+10% +$856K ﹤0.01% 2131
2023
Q2
$4.29M Buy
67,862
+3,989
+6% +$242K ﹤0.01% 2775
2023
Q1
$2.17M Buy
63,873
+1,407
+2% +$73.5K ﹤0.01% 2991
2022
Q4
$3.61M Buy
62,466
+2,676
+4% +$165K ﹤0.01% 2831
2022
Q3
$5.62M Sell
59,790
-1,584
-3% -$225K ﹤0.01% 2606
2022
Q2
$13.7M Buy
61,374
+1,792
+3% +$600K ﹤0.01% 2032
2022
Q1
$32.8M Buy
59,582
+2,594
+5% +$1.57M ﹤0.01% 1554
2021
Q4
$37.7M Buy
56,988
+2,446
+4% +$1.87M ﹤0.01% 1514
2021
Q3
$45.8M Sell
54,542
-667
-1% -$677K 0.01% 1352
2021
Q2
$70.1M Buy
55,209
+4,645
+9% +$5.24M 0.01% 1026
2021
Q1
$55.5M Buy
50,564
+8,562
+20% +$11.3M 0.01% 1142
2020
Q4
$60M Buy
42,002
+2,253
+6% +$2.4M 0.01% 982
2020
Q3
$28.1M Buy
39,749
+3,952
+11% +$2.87M 0.01% 1278
2020
Q2
$25.1M Buy
35,797
+6,090
+21% +$3.52M 0.01% 1333
2020
Q1
$10.4M Buy
29,707
+5,593
+23% +$3.96M ﹤0.01% 1719
2019
Q4
$15.2M Buy
24,114
+2,964
+14% +$1.45M ﹤0.01% 1733
2019
Q3
$7.09M Buy
21,150
+3,041
+17% +$975K ﹤0.01% 2160
2019
Q2
$4.7M Buy
18,109
+6,644
+58% +$1.33M ﹤0.01% 2437
2019
Q1
$1.9M Buy
11,465
+3,463
+43% +$563K ﹤0.01% 2886
2018
Q4
$866K Buy
8,002
+561
+8% +$94.6K ﹤0.01% 3157
2018
Q3
$1.86M Buy
7,441
+1,876
+34% +$404K ﹤0.01% 2927
2018
Q2
$1.21M Buy
5,565
+1,014
+22% +$188K ﹤0.01% 3100
2018
Q1
$665K Buy
+4,551
New +$770K ﹤0.01% 3296

Other funds holding CDLX

Geode Capital Management's CDLX Position: Q1 2026 in Review

Geode Capital Management increased its Cardlytics (CDLX) stake by 12% in Q1 2026, buying an estimated $77.8K and bringing the position to 73,423 shares worth $771K. The position accounts for ﹤0.01% of the portfolio, ranked #3439.

Geode Capital Management first reported a position in CDLX in Q1 2018 and has held it in 33 quarters since. The position peaked at $70.1M in Q2 2021. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Geode Capital Management held 73,423 shares of Cardlytics worth $771K as of Q1 2026.
  • Geode Capital Management bought 7,976 Cardlytics shares in Q1 2026, an estimated $77.8K.
  • Cardlytics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3439 holding.
  • Geode Capital Management first reported a position in Cardlytics in Q1 2018 and has held it in 33 quarters since.
  • Geode Capital Management's Cardlytics position peaked at $70.1M in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.